Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3706 | Standard Incentive Wiki | 1.00 |
| drug4366 | allogeneic mesenchymal stem cell Wiki | 1.00 |
| drug2916 | Placebo Wiki | 0.04 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
A randomized controlled trial will test the effectiveness of social incentives relative to traditional incentives in promoting walking behavior among college students (N=200). Participants who are rewarded for walking together will be compared to those who are rewarded for walking even when alone. Research participants will download activity tracking apps (Fitbit app and AWARE app) that provide activity and location data. Participants will be consented and then randomized to one of two incentive schemes for walking. Over a 2-week intervention period, the standard incentive group will earn $2 per day when they meet their walking goal regardless of whether they walk alone or with others. The social incentive group will earn $1 per day when they reach their walking goal plus an additional $1 when they walk at least 2000 steps with their walking partner. The incentive scheme will be in place for 2-weeks, preceded by a 1-week baseline period and followed by a 2-week follow-up period.
Description: Change in mean daily steps walked from baseline to intervention period, as recorded on the FitBit app
Measure: Change in mean daily steps walked Time: week 2-3Description: Change in mean daily steps walked from baseline to follow-up period, as recorded on the FitBit app
Measure: Change in mean daily steps walked Time: week 4-5Description: Number of days when number of steps walked was at or above daily goal
Measure: Met daily step goal Time: week 2-3Description: Number of days when number of steps walked was at or above daily goal
Measure: Met daily step goal Time: week 4-5Description: 20-item scale measuring subjective feelings of loneliness and social isolation. Minimum score = 0; maximum score = 60; higher scores indicate more loneliness
Measure: Change in score on University of California Los Angeles (UCLA) Loneliness Scale (survey measure) Time: week 5Description: Number of days with self report of walking at least 2,000 steps with another participant
Measure: Number of days participant walked together with partner (self report) Time: week 2-3Description: Number of days with self report of walking at least 2,000 steps with another participant
Measure: Number of days participant walked together with partner (self report) Time: week 4-5Description: A machine learning (ML) algorithm will compare the walking records from the Aware app of each dyad of participants and assess whether they walked together on each day
Measure: Number of days participant walked together with partner (coded) Time: week 2-3Description: A machine learning (ML) algorithm will compare the walking records from the Aware app of each dyad of participants and assess whether they walked together on each day
Measure: Number of days participant walked together with partner (coded) Time: week 4-5Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports